The Man in the Shadows: Migraine Doesn’t Care About Your Gender

The Lie I Carried for Years

The doctor didn’t say anything cruel. He just paused — a small recalibration, furniture being moved — and offered: “You know this is more of a women’s thing, right?”

I was in my early twenties. I nodded. And somewhere in that nod, I agreed to make my own pain smaller.

I’ve lived with migraine for 30 years. I’m a man. These two facts have never been in conflict — not biologically, not neurologically, not in any way that matters. But the world spent decades insisting, quietly and sometimes loudly, that they might be. That I was borrowing something. That the attacks shutting me down in a dark room were somehow less legitimate than they would have been in a different body.

This article is about why that perception exists, why it causes real harm, and what the science now says with increasing clarity.

Migraine doesn’t care what’s in your chromosomes. It never did.

The Number Nobody Mentions

Migraine affects approximately 1 in 6 women — and 1 in 15 men worldwide.^[1] That gap is real. It matters scientifically. It drove decades of research focused primarily on women, which left men in a clinical shadow long enough that we started believing we didn’t belong in the conversation.

But here is what gets lost in that statistic: 1 in 15 is not a rounding error. It’s hundreds of millions of people.

The Global Burden of Disease Study 2021 — the most comprehensive epidemiological analysis ever conducted on migraine — found that global prevalence increased by 58% between 1990 and 2021.^[2] Among male individuals, the rate of increase was four to five times faster than among females. Men aren’t catching up to women in migraine. They’re accelerating toward a burden the medical system never prepared for.

A 2025 analysis of GBD data specifically tracking males aged 10–59 found a telling pattern: incidence peaks in adolescence, between ages 10 and 14, while prevalence and disability peak in the middle-aged group, 30 to 44.^[3] Those are working years. Career years. The years when a man is most likely to be told — or to tell himself — that pain is not an acceptable reason to stop.

And so many don’t stop. They push through. They don’t name it. They disappear into dark rooms and come out saying they’re fine.

Why Men Stay Silent

The 2023 EMHA Stigma Survey, conducted across 17 European countries with 4,210 respondents, found that people with migraine wait an average of five years for a diagnosis — then an additional three years before receiving appropriate care.^[4] For men, the clock often doesn’t even start. The barriers come before the waiting room.

Researchers tracking the 30-year global burden named the mechanism directly: traditional sex and gender roles, combined with higher pain tolerance expectations, may lead to underdiagnosis and undertreatment in men with migraine.^[2] In plain language: men are taught to endure. Asking for help feels like failing a test nobody handed you but everyone expects you to pass.

The American Migraine Foundation states it without softening: for the millions of men who live with migraine, there is often pressure to push through or struggle in silence. The myth that migraine is a woman’s disease prevents many men from recognizing their own symptoms for what they are.^[5]

I know this from the inside. For years I called my attacks “bad headaches” — to doctors, to colleagues, to myself. The word migraine felt borrowed. Like I was reaching into someone else’s medicine cabinet without permission.

And the disease itself makes this worse. Migraine is invisible. There’s no blood test, no scan, no marker you can point to. Diagnosis is built entirely from symptoms — which means it depends entirely on the patient’s willingness to report them fully and honestly. When you’ve been conditioned to minimize pain, you become a poor historian of your own suffering. You underreport. Doctors under-suspect. The gap between disease burden and clinical recognition stays wide, year after year, attack after attack.

When the Symptoms Don’t Fit the Textbook

There’s another layer to the underdiagnosis problem — and it’s not about willingness. It’s about biology.

The International Classification of Headache Disorders (ICHD-3) describes migraine as unilateral, pulsating pain, worsened by movement, accompanied by nausea, photophobia, and phonophobia. That diagnostic checklist was constructed largely from data skewed toward women. It describes female migraine well. It describes male migraine imperfectly.

A 2025 comprehensive narrative review published in The Journal of Headache and Pain found that men with migraine often exhibit atypical symptoms compared to the ICHD-3 criteria and are less likely to report common associated symptoms — nausea, light sensitivity, sound sensitivity.^[6] Male attacks tend to be shorter. The pain character may differ. The whole clinical picture can look enough like “a severe headache” that both patient and physician miss it — not from negligence, but because the map was drawn for someone else.

This diagnostic confusion is further complicated by another neurological condition that actually does skew heavily male: cluster headache. Cluster affects men disproportionately — excruciating periorbital pain, tearing, agitation, attacks that last 15 minutes to 3 hours and strike in cyclical patterns. It is frequently misdiagnosed as migraine and vice versa.^[7] Men navigating that diagnostic fog can spend years on wrong treatments for the wrong condition while the right one goes unnamed.

The system was not built to find them. And so, it often doesn’t.

What the Biology Actually Says

Why do fewer men get migraine? The honest answer: we don’t fully know. The research has only recently begun to ask the right questions about the right people.

What we do know involves hormones — but not in the simple way the “women’s disease” narrative implies.

Estrogen fluctuations are a well-established migraine trigger, which partly explains the higher prevalence in women during reproductive years.^[8] In men, the hormonal environment is more stable, which may offer some protection. But “some protection” is not “immunity,” and the biology of male migraine turns out to be more nuanced than a simple hormone-deficiency story.

The relationship between androgens and migraine is not straightforward — and earlier research has suggested that men with migraine more frequently report symptoms of androgen deficiency even when their testosterone levels appear normal.^[10]

CGRP — the neuropeptide at the center of modern migraine biology and the target of the newest preventive therapies — also behaves differently across sexes. Animal models show sex-specific CGRP expression in trigeminal pathways.^[6] The clinical implications for male-specific treatment are still being worked out.

The important point is this: male migraine is not simply female migraine with fewer hormones. It’s a distinct phenotype that has spent decades being understudied, misclassified, and left in the margins of a literature that wasn’t looking for it. That is beginning to change. Slowly. Not fast enough.

The Cost of Staying Hidden

When men don’t seek care, the consequences are not abstract.

The OVERCOME study found that men with migraine were significantly less likely to consult a headache specialist or use prescription acute medications compared to women.^[11] Undertreated attacks. More lost workdays. More nights on the floor of a dark room, without a name for what’s happening, without a plan.

I did this. For years, I added shame to the pain. I made migraine harder than it needed to be by believing, on some level, that it wasn’t entirely mine to claim.

That belief cost me time. It cost me attacks I could have shortened. It cost me treatments I could have started sooner. Shame is not neutral. It has a clinical price.

A Letter to the Man in the Dark Room

If you’re reading this in the aftermath of an attack — when your head is quiet enough to look at a screen, when the nausea has passed, when you’ve told everyone you’re fine — I want to say something directly.

This is real. What happened to your head is real. It has a name. It has biological mechanisms involving the trigeminal nerve, CGRP, cortical spreading depression, the brainstem. It is the second most disabling neurological condition on the planet.^[13] It is not a personality flaw. It is not weakness. It is not borrowed from someone else’s experience.

You are 1 in 15. There are hundreds of millions of men in that number. You are not alone in the dark.

Go to a doctor. Say the word migraine. Bring a headache diary if it helps. Ask about triptans. Ask about CGRP monoclonal antibodies. Ask about preventive treatment. These are not women’s medications. They are migraine medications — and they can work for you.

Migraine doesn’t care about your gender. Neither should your treatment.